Efficacy and Safety of Baricitinib in Patients With Refractory Alopecia Areata
October 2022
in “Dermatologic Therapy”
TLDR Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.
The study "Efficacy and safety of baricitinib in patients with refractory alopecia areata" conducted by Yuqian Wang and colleagues involved 11 patients with refractory alopecia areata (AA) who were treated with baricitinib. All patients had previously received at least one therapy for more than a year, including minoxidil, steroids, phototherapy, acupuncture, or herbal medicine, but the response was poor. After 20 weeks of treatment with baricitinib, 2 patients (18%) achieved complete hair regrowth, 6 patients (55%) had partial hair regrowth, and 3 patients (27%) had no hair regrowth. Adverse events were mild and included nausea, folliculitis, and mild increases in liver transaminase levels. The study concluded that baricitinib is efficacious in treating refractory AA, but further trials are needed to confirm its safety and efficacy.
View this study on onlinelibrary.wiley.com →
Cited in this study
research Two Phase 3 Trials of Baricitinib for Alopecia Areata
Baricitinib was effective in treating alopecia areata in two major trials.
research The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
research Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
Baricitinib is effective and safe for treating severe alopecia areata.
research JAK inhibition in the treatment of alopecia areata – a promising new dawn?
JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.
research JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.
research Alopecia areata
Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.
Related
research Alopecia areata: A multifactorial autoimmune condition
Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.
research Linear alopecia areata
research Treating of resistant cases of alopecia universalis
Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.